In this study, we used immunohistochemistry to investigate the MMP‐7, ‐8, ‐9, beta‐catenin, and E‐cadherin immunoexpression in primary and recurrent ameloblastoma tissue samples from 34 patients. Here, CTNNB1 is linked to ameloblastoma.